<a href="https://www.fiercebiotech.com/biotech/alnylam-pays-inceptive-30m-transform-sirna-design-ai-pioneer" hreflang="en">Alnylam pens $2B deal with Inceptive to transform siRNA design with AI pioneer</a>

- Alnylam is betting big on Inceptive Nucleics, a startup founded by Jakob Uszkoreit, the former Google Brain lead who helped shape ChatGPT. The $30 million deal aims to use AI to redesign siRNA drugs, moving beyond traditional trial-and-error to algorithmic precision. It’s a fascinating crossover: the architect of modern LLMs now applying that same pattern-recognition power to molecular biology. While the headline screams biotech, the real story is the digital infrastructure of drug discovery. This isn’t just about curing disease; it’s about treating biology as code. For Crypto Express 3000, this signals a deeper integration of AI into life sciences, where data models replace petri dishes. A quiet revolution in med-tech, driven by silicon rather than serum.